BioSpace News Archive

Alagille Syndrome Treatment Market: Rising awareness about Alagille syndrome is projected to propel the market

Alagille syndrome is a rare genetic disorder that affects various organs including the liver, kidney, heart, eyes, and blood vessels. In this condition, bile accumulates in the liver and causes liver damage.

April 27, 2021
·
4 min read
Adhesion Barrier Market is expected to witness a moderate growth by 2028

Extensive research and development in the medical field has aided the market to grow fast. Adhesion barriers are medical devices that are used to descend or reduce post-operative complications.

April 27, 2021
·
5 min read
Policy

Bumrungrad International Hospital Achieves GHA Accreditation for the Second Time

Bumrungrad International Hospital, one of Asia’s top medical destinations, has been awarded “Accreditation with Excellence” for a second consecutive term by Global Healthcare Accreditation for its medical travel services.

April 27, 2021
·
4 min read
Business

Modra Pharmaceuticals Appoints Two New Supervisory Board Members Adding Significant Experience in Corporate and Clinical Development

Modra Pharmaceuticals announced the appointment of Hemanshu Shah, Ph.D., MBA and Klaus Schollmeier, Ph.D. to its supervisory board.

April 27, 2021
·
2 min read
MS Society of Canada Awards $1 Million to Research Study on Utilizing Artificial Intelligence to Support Treatment Decisions in Multiple Sclerosis

Dr. Douglas Arnold from The Neuro at McGill University receives AI & MS Discovery Grant supported by TD Bank Group through the TD Ready Commitment.

April 27, 2021
·
3 min read
Policy

ENZYVANT Resubmits Biologics Licensing Application (BLA) to FDA for RVT-802 for Pediatric Congenital Athymia

Enzyvant announced the resubmission of the Biologics Licensing Application to the U.S. Food and Drug Administration for RVT-802, cultured human thymus tissue.

April 27, 2021
·
3 min read
Business

Centene Corporation Reports First Quarter 2021 Results And Increases 2021 Guidance

Centene Corporation announced its financial results for the first quarter ended March 31, 2021, reporting diluted earnings per share of $1.19 and adjusted diluted EPS of $1.63.

April 27, 2021
·
26 min read
Business

Terasaki Institute for Biomedical Innovation Announces Inaugural Leadership Board

The Terasaki Institute for Biomedical Innovation announces the establishment of the inaugural Leadership Board.

April 27, 2021
·
2 min read
Pharm Country

New Harris Survey Reveals Chronic Nasal Congestion Is Surprisingly Widespread: Nearly 1 in 4 Americans With Nasal Congestion Experience Symptoms Almost Every Day

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, announced results of a new nationwide survey on chronic nasal congestion, its impact on daily activities, and awareness of nasal polyps as a possible cause.

April 27, 2021
·
5 min read
BioMidwest

DaVita Solidifies Commitment to ESG, Sets 2025 Goals

DaVita Inc. announced its 2025 Environmental, Social and Governance goals and released its new ESG reports, bolstering its commitment to corporate citizenship and helping create healthy communities.

April 27, 2021
·
5 min read